Mirae Asset Global Investments Co., Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 97,544 shares of RXRX stock, worth $742,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,544
Previous 105,672
7.69%
Holding current value
$742,309
Previous $1.04 Million
6.63%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RXRX
# of Institutions
270Shares Held
193MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$187 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$183 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$122 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$93.8 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V711.9MShares$90.6 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.37B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...